Turnstone Biologics Corp.(NASDAQ:TSBX) 
Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy.
Website: https://turnstonebio.com/
Founded: 2014
IPO Price: $12 (Jul 21, 2023)
Sector: TECHNOLOGY
Industry: GENERAL
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-02-11
P
O 0.44
H 0.45
L 0.40
C 0.41
V 608,115
10EMA 0.41
20EMA 0.41
60EMA 0.41
120EMA 0.41
250EMA 0.41